Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo

被引:286
作者
Shen, LJ
Sigal, LJ
Boes, M
Rock, KL [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
D O I
10.1016/j.immuni.2004.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system detects viral infections and mutations in parenchymal cells when antigens from these cells are crosspresented on MHC class I molecules of professional antigen-presenting cells (APC). Exogenous antigens are crosspresented through TAP-dependent (cytosolic) or poorly understood TAP-independent (vacuolar) pathways. The TAP-independent pathway is blocked by the cysteine protease inhibitor, leupeptin, but not by proteasome inhibitors, which is opposite to the effects of these agents on the TAP-dependent pathway. Dendritic cells lacking the cysteine protease cathepsin S lack the TAP-independent pathway. Mice whose APC lack cathepsin S have reduced crosspriming to particulate and cell-associated antigens, as well as to influenza virus. Cathepsin S-deficient phagosomes generate a class I-presented peptide poorly. In contrast, cathepsin S-sufficient phagosomes and recombinant cathepsin S produce the mature epitope. Therefore, cathepsin S plays a major role in generating presented peptides for the vacuolar pathway of cross-presentation, and this mechanism is active in vivo.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 59 条
[11]   Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells [J].
Fonteneau, JF ;
Kavanagh, DG ;
Lirvall, M ;
Sanders, C ;
Cover, TL ;
Bhardwaj, N ;
Larsson, M .
BLOOD, 2003, 102 (13) :4448-4455
[12]   Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming [J].
Freigang, S ;
Egger, D ;
Bienz, K ;
Hengartner, H ;
Zinkernagel, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13477-13482
[13]   ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells [J].
Guermonprez, P ;
Saveanu, L ;
Kleijmeer, M ;
Davoust, J ;
van Endert, P ;
Amigorena, S .
NATURE, 2003, 425 (6956) :397-402
[14]   Cross-presentation, dendrttic cells, tolerance and immunity [J].
Heath, WR ;
Carbone, FR .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :47-64
[15]   Phagosomes are competent organelles for antigen cross-presentation [J].
Houde, M ;
Bertholet, S ;
Gagnon, E ;
Brunet, S ;
Goyette, G ;
Laplante, A ;
Princiotta, MF ;
Thibault, P ;
Sacks, D ;
Desjardins, M .
NATURE, 2003, 425 (6956) :402-406
[16]   In vivo cross-priming of MHC class I - Restricted antigens requires the TAP transporter [J].
Huang, AYC ;
Bruce, AT ;
Pardoll, DM ;
Levitsky, HI .
IMMUNITY, 1996, 4 (04) :349-355
[17]   ROLE OF BONE-MARROW-DERIVED CELLS IN PRESENTING MHC CLASS I-RESTRICTED TUMOR-ANTIGENS [J].
HUANG, AYC ;
GOLUMBEK, P ;
AHMADZADEH, M ;
JAFFEE, E ;
PARDOLL, D ;
LEVITSKY, H .
SCIENCE, 1994, 264 (5161) :961-965
[18]   In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens [J].
Jung, S ;
Unutmaz, D ;
Wong, P ;
Sano, GI ;
De los Santos, K ;
Sparwasser, T ;
Wu, SJ ;
Vuthoori, S ;
Ko, K ;
Zavala, F ;
Pamer, EG ;
Littman, DR ;
Lang, RA .
IMMUNITY, 2002, 17 (02) :211-220
[19]   Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo [J].
Kleindienst, P ;
Brocker, T .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :2817-2823
[20]   EFFICIENT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS ANTIGEN UPON PHAGOCYTOSIS BY MACROPHAGES [J].
KOVACSOVICSBANKOWSKI, M ;
CLARK, K ;
BENACERRAF, B ;
ROCK, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :4942-4946